The impact of nonsteroidal anti-inflammatory drugs on inflammatory response after aneurysmal subarachnoid hemorrhage

Neurocritical Care

Volumn 20, Issue 2, 2014, Pages 240-246

  Muroi, Carl ^a,b   Hugelshofer, Michael ^a   Seule, Martin ^a   Keller, Emanuela ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Department of Neurosurgery Kantonsspital Aarau ^*  (Switzerland)

Author keywords

Inflammation; Interleukin 6; Nonsteroidal anti inflammatory drugs; Subarachnoid hemorrhage

Indexed keywords

C REACTIVE PROTEIN; DICLOFENAC; DIPYRONE; IBUPROFEN; INTERLEUKIN 6; PARACETAMOL; ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANGIOGRAPHY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE MARKER; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; GLASGOW COMA SCALE; HUMAN; INDUCED HYPOTHERMIA; INFECTIOUS COMPLICATION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; AGED; BLOOD; CLINICAL PRACTICE; GLASGOW OUTCOME SCALE; IMMUNOLOGY; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; UTILIZATION;

ACETAMINOPHEN; ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; C-REACTIVE PROTEIN; DICLOFENAC; DIPYRONE; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; HYPOTHERMIA, INDUCED; IBUPROFEN; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; SEVERITY OF ILLNESS INDEX; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 84896546365     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-013-9930-2     Document Type: Article

References (38)

1. Muroi C, Seule M, Mishima K, Keller E. Novel treatments for vasospasm after subarachnoid hemorrhage. Curr Opin Crit Care. 2012;18:119-26.
2. Chaichana KL, Pradilla G, Huang J, Tamargo RJ. Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage. World Neurosurg. 2010;73:22-41.
3. Muroi C, Mink S, Seule M, et al. Monitoring of the inflammatory response after aneurysmal subarachnoid haemorrhage in the clinical setting: review of literature and report of preliminary clinical experience. Acta Neurochir Suppl. 2011;110:191-6.
4. Prunell GF, Svendgaard NA, Alkass K, Mathiesen T. Inflammation in the brain after experimental subarachnoid hemorrhage. Neurosurgery. 2005;56:1082-92.
5. Muroi C, Hugelshofer M, Seule M, et al. Correlation among systemic inflammatory parameter, occurrence of delayed neurological deficits, and outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2013;72:367-75.
6. Ayer R, Jadhav V, Sugawara T, Zhang JH. The neuroprotective effects of cyclooxygenase-2 inhibition in a mouse model of aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl. 2011;111:145-9.
7. Chyatte D. Prevention of chronic cerebral vasospasm in dogs with ibuprofen and high-dose methylprednisolone. Stroke. 1989;20:1021-6. (Pubitemid 19204014)
8. Frazier JL, Pradilla G, Wang PP, Tamargo RJ. Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage. J Neurosurg. 2004;101:93-8. (Pubitemid 38808466)
9. Fukumori T, Tani E, Maeda Y, Sukenaga A. Effects of prostacyclin and indomethacin on experimental delayed cerebral vasospasm. J Neurosurg. 1983;59:829-34. (Pubitemid 13021757)
10. Hakan T, Berkman MZ, Ersoy T, et al. Anti-inflammatory effect of meloxicam on experimental vasospasm in the rat femoral artery. J Clin Neurosci. 2008;15:55-9. (Pubitemid 350192250)
11. Tani E, Maeda Y, Fukumori T, et al. Effect of selective inhibitor of thromboxane A2 synthetase on cerebral vasospasm after early surgery. J Neurosurg. 1984;61:24-9. (Pubitemid 14081288)
12. Lerch C, Yonekawa Y, Muroi C, Bjeljac M, Keller E. Specialized neurocritical care, severity grade, and outcome of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2006;5: 85-92. (Pubitemid 44729632)
13. Keller E, Krayenbuhl N, Bjeljac M, Yonekawa Y. Cerebral vasospasm: results of a structured multimodal treatment. Acta Neurochir Suppl. 2005;94:65-73.
14. Seule MA, Muroi C, Mink S, Yonekawa Y, Keller E. Therapeutic hypothermia in patients with aneurysmal subarachnoid hemorrhage, refractory intracranial hypertension, or cerebral vasospasm. Neurosurgery. 2009;64:86-92.
15. Oda S, Hirasawa H, Shiga H, et al. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine. 2005;29:169-75. (Pubitemid 40126235)
16. Muroi C, Frei K, El Beltagy M, et al. Combined therapeutic hypothermia and barbiturate coma reduces interleukin-6 in the cerebrospinal fluid after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2008;20:193-8.
17. Vergouwen MD, Ilodigwe D, Macdonald RL. Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke. 2011;42: 924-9.
18. Rosen DS, Macdonald RL. Grading of subarachnoid hemorrhage: modification of the world World Federation of Neurosurgical Societies scale on the basis of data for a large series of patients. Neurosurgery. 2004;54:566-75.
19. Nieuwkamp DJ, Rinkel GJ, Silva R, et al. Subarachnoid haemorrhage in patients > or = 75 years: clinical course, treatment and outcome. J Neurol Neurosurg Psychiatry. 2006;77:933-7. (Pubitemid 44174077)
20. Scaravilli V, Tinchero G, Citerio G. Fever management in SAH. Neurocrit Care. 2011;15:287-94.
21. Juvela S, Kuhmonen J, Siironen J. C-reactive protein as predictor for poor outcome after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 2012;154:397-404.
22. Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J. 2008; 22:383-90. (Pubitemid 351225574)
23. Hinz B, Cheremina O, Bachmakov J, et al. Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic. FASEB J. 2007;21:2343-51 Epub 007 Apr 13.
24. Diaz-Gonzalez F, Sanchez-Madrid F. Inhibition of leukocyte adhesion: an alternative mechanism of action for anti-inflammatory drugs. Immunol Today. 1998;19:169-72. (Pubitemid 28216057)
25. Hamza M, Dionne RA. Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition. Curr Mol Pharmacol. 2009;2:1-14.
26. Beydon L, Audibert G, Berre J, et al. Pain management in severe subarachnoid haemorrhage. Ann Fr Anesth Reanim. 2005;24: 782-6. (Pubitemid 40942087)
27. Binhas M, Walleck P, El Bitar N, et al. Pain management in subarachnoid haemorrhage: a survey of French analgesic practices. Ann Fr Anesth Reanim. 2006;25:935-9. (Pubitemid 44425277)
28. Parkhutik V, Lago A, Tembl JI, et al. Influence of COX-inhibiting analgesics on the platelet function of patients with subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2012;21:755-9.
29. Broessner G, Beer R, Lackner P, et al. Prophylactic, endovascularly based, long-term normothermia in ICU patients with severe cerebrovascular disease: bicenter prospective, randomized trial. Stroke. 2009;40:e657-65.
30. Broessner G, Lackner P, Fischer M, et al. Influence of prophylactic, endovascularly based normothermia on inflammation in patients with severe cerebrovascular disease: a prospective, randomized trial. Stroke. 2010;41:2969-72.
31. Thai QA, Oshiro EM, Tamargo RJ. Inhibition of experimental vasospasm in rats with the periadventitial administration of ibuprofen using controlled-release polymers. Stroke. 1999;30:140-7. (Pubitemid 29029455)
32. White RP, Robertson JT. Comparison of piroxicam, meclofenamate, ibuprofen, aspirin, and prostacyclin efficacy in a chronic model of cerebral vasospasm. Neurosurgery. 1983;12:40-6. (Pubitemid 13181856)
33. Zhang Y, Wang X, Baranov SV, et al. Dipyrone inhibits neuronal cell death and diminishes hypoxic/ischemic brain injury. Neurosurgery. 2011;69:942-56.
34. Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab. 2008;28:1761-70.
35. Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;17(4):CD006184.
36. van den Bergh WM, Group MS, Algra A, et al. Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH study. Stroke. 2006;37:2326-30.
37. Aibiki M, Maekawa S, Ogura S, et al. Effect of moderate hypothermia on systemic and internal jugular plasma IL-6 levels after traumatic brain injury in humans. J Neurotrauma. 1999; 16:225-32. (Pubitemid 29141139)
38. Abe R, Hirasawa H, Oda S. Influence of brain hypothermia on blood Interleukin-6 levels on postresuscitated patients after cardiac arrest. In: Hayashi N, Bullock R, Dietrich DX, Maekawa T, Tamura A, editors. Hypothermia for acute brain damage. Tokyo Berlin Heidelberg: Springer; 2004. p. 315-9.